SOPH Chief Scientific Officer Xu Zhenyu Sells 4,000 Shares

What Happened
Xu Zhenyu, Chief Scientific Officer of SOPHiA GENETICS SA (SOPH), sold 4,000 shares on 2026-06-15 in an open-market transaction. The reported weighted-average sale price was $5.01 per share, for total proceeds of $20,056. This was a sale (S), not a purchase.

Key Details

• Transaction date: 2026-06-15; Form 4 filed: 2026-06-17 (timely filing).
• Price: weighted average $5.01; shares sold in multiple trades at prices ranging $4.90 to $5.13. The filer can provide a per-price breakdown on request.
• Total shares sold: 4,000; total proceeds reported: $20,056.
• Transaction made pursuant to a pre-established Rule 10b5-1(c) trading plan (footnote).
• Shares owned after the transaction: not disclosed in this filing.

Context
Sales executed under a 10b5-1 plan are pre-arranged and often reflect scheduled, routine dispositions rather than a contemporaneous view of the company. For retail investors, purchases typically signal stronger insider conviction than routine sales; this filing documents a modest, planned sale by a company executive.